Abstract:BackgroundThe escalating prevalence of allergic diseases on a global scale, affecting approximately 20% of the world's population, has become a significant health concern. Clinical determination of total IgE in serum and plasma is used as an aid to the diagnosis of allergic diseases. The tIgE CLIA Microparticles Kit is a chemiluminescent microparticle immunoassay for the quantitative determination of total IgE concentrations in human serum. This kit, integrated with the AutoLumo® 2000 Plus Analyzer, offers an automated, cutting-edge platform for total IgE detection. This streamlined combination provides clinicians with a reliable tool for comprehensive and efficient allergic diseases diagnosis.MethodsThe performance of tIgE CLIA Microparticles Kit was evaluated on AutoLumo® A2000 Plus automated chemiluminescence analyzer and compared to a well-characterized platform (Elecsys IgE II on Cobas e601, Roche). This assay is based upon the two-step sandwich method. During detection, the patient sample and the anti-IgE coated microparticles solution were added sequentially. Unbound components were washed off after incubation. The formation of a complex occurred with the subsequent addition of a HRP conjugated anti-IgE antibody solution. The catalysis of chemiluminescent substrates by this complex generated a measurable light signal recorded as RLUs (Relative Light Units). A 2-point calibrator was used to analyze the tIgE antibody concentrations in the serum sample. The limit of blank (LoB), limit of detection (LoD), limit of quantitation (LoQ), accuracy, repeatability, linearity, specificity, on-board stability and real-time stability of the assay kit were evaluated. Serum samples (n=220) that had been previously well characterized were used for method comparisons.ResultsThe tIgE CLIA Microparticles assay demonstrated a measurement range of 5-2500 IU/mL, with LoB, LoD, and LoQ values of ≤3 IU/mL, ≤4 IU/mL, and ≤5 IU/mL, respectively. The accuracy of the assay kit was assessed by trueness and precision following CLSI EP15-A2 and EP5-A2 guidelines. The trueness was evaluated using WHO IRP 11/234 as the reference standard, the estimate %bias between the expected and measured mean value was ≤5%. The average %CV of the intra-run and inter-run precision were 5.00% and 3.24% respectively, with a linearity of R≥0.990. The specificity to tIgE is evident, with no cross-reactivity to IgA, IgG, and IgM (≤100 μg/mL), and minimal interference from rheumatoid factor (RF) and anti-nuclear antibodies (ANA) ( 0.990) and the bias was within 15% when compared to a reference kit according to the CLSI EP9-A2 guideline.ConclusionsAutolumo® Analyzers, in conjunction with the tIgE CLIA Microparticles Assay, presents a fully automated chemiluminescence immunoassay platform for accurate and cost-effective screening to aid allergic diseases diagnostics with excellent specificity, precision, and on-board stability.

Aptamer‐based Detection and Quantitative Analysis of Human Immunoglobulin E in Capillary Electrophoresis with Chemiluminescence Detection

Aptameric System for the Highly Selective and Ultrasensitive Detection of Protein in Human Serum Based on Non-Stripping Gold Nanoparticles

An Electrochemiluminescence Aptasensor Based on Cdse/Zns Functionalized Mos2 and Enzymatic Biocatalytic Precipitation for Sensitive Detection of Immunoglobulin E

Aptamer-Barcode Based Immunoassay for the Instantaneous Derivatization Chemiluminescence Detection of Ige Coupled to Magnetic Beads

An Electrochemiluminescence Aptasensor Based on Flowerlike CdS–MoS2 Composites and DNAzyme for Detection of Immunoglobulin E

Detection of Immunoglobulin E Using an Aptamer Based Dot-Blot Assay

Sandwich-type electrochemiluminescence immunosensor based on N-(aminobutyl)-N-ethylisoluminol labeling and gold nanoparticle amplification.

Ultrasensitive Electrochemiluminescence Immunosensor Based on Luminol Functionalized Gold Nanoparticle Labeling.

Aptamer-Au NPs conjugates-accumulated methylene blue for the sensitive electrochemical immunoassay of protein.

Electrochemiluminescence Immunoassay Platform with Immunoglobulin G-Encapsulated Gold Nanoclusters as a “Two-In-One” Probe

Ultrasensitive detection of IgE levels based on magnetic nanocapturer linked immunosensor assay for early diagnosis of cancer

B-044 Development and Evaluation of an Assay for the Detection of Human Total IgE in Serum on the Fully Automated Chemiluminescence Immunoassay Platform - Autolumo® 2000 Plus Analyzer

Magnetic beads based immunoaffinity capillary electrophoresis of total serum IgE with laser-induced fluorescence detection.

Label-free amperometric immunobiosensor based on a gold colloid and Prussian blue nanocomposite film modified carbon ionic liquid electrode

Fluorescence enhancement of silver nanoparticle hybrid probes and ultrasensitive detection of IgE.

A simple and convenient electrochemiluminescence immunoassay by using gold nanoparticles as both label and co-reactant

Antifouling and ultrasensitive biosensing interface based on self-assembled peptide and aptamer on macroporous gold for electrochemical detection of immunoglobulin E in serum

Microfluidic system for high-throughput immunoglobulin-E analysis from clinical serum samples

Optical Label-Free Aptasensor Based on Weak Value Amplification for Real-Time and Ultrasensitive Detection of IgE

Sensitive sandwich immunoassay based on single particle mode inductively coupled plasma mass spectrometry detection.

A novel protein analytical method based on hybrid-aptamer and DNA-arrayed electrodes